59 Publications (Page 2 of 3)
2016
?-catenin nuclear translocation in colorectal cancer cells is suppressed by PDE10A inhibition, cGMP elevation, and activation of PKG
Lee, K.Lindsey, A.S.Li, N.Gary, B.Andrews, J.Keeton, A.B. and Piazza, G.A.
Oncotarget, vol. 7, pp. 5353-5365. | Journal Article
 
Increasing the endoplasmic reticulum pool of the F508del allele of the cystic fibrosis transmembrane conductance regulator leads to greater folding correction by small molecule therapeutics
Chung, WChung, W JChung, W.J.Goeckeler-Fried, Jennifer LGoeckeler-Fried, JenniferGoeckeler-Fried, J.L.Havasi, ViktoriaHavasi, ViktoriaHavasi, V.Chiang, AnnetteChiang, AnnetteChiang, A.Rowe, S.M.Rowe, StevenRowe, Steven MPlyler, Zackery EPlyler, ZackeryPlyler, Z.E.Hong, Jeong SHong, JeongHong, J.S.Mazur, M.Mazur, MarinaMazur, MarinaPiazza, G.A.Piazza, Gary APiazza, GaryKeeton, AdamKeeton, A.B.Keeton, Adam BWhite, E.L.White, EWhite, E LRasmussen, LynnRasmussen, L.Rasmussen, LynnWeissman, A.M.Weissman, AllanWeissman, Allan MDenny, RBrodsky, Jeffrey LBrodsky, J.L.Brodsky, Jeffrey and Sorscher, Eric J
PLoS ONE, vol. 11. | Journal Article
 
Metabolism and growth inhibitory activity of cranberry derived flavonoids in bladder cancer cells
Prasain, J.K.Rajbhandari, R.Keeton, A.B.Piazza, G.A. and Barnes, S.
Food and Function, vol. 7, pp. 4012-4019. | Journal Article
 
Sulindac sulfide selectively increases sensitivity of ABCC1 expressing tumor cells to doxorubicin and glutathione depletion.
Whitt, Jason DKeeton, Adam BGary, Bernard DSklar, Larry ASodani, KamleshChen, Zhe-Sheng and Piazza, Gary A
Journal of biomedical research, vol. 30, (no. 2), pp. 120-133, March 2016. | Journal Article
 
Synthesis and Optimization of New 3,6-Disubstitutedindole Derivatives and Their Evaluation as Anticancer Agents Targeting the MDM2/MDMx Complex
Rezk, Mohamed SalahAbdel-Halim, MohammadKeeton, AdamFranklin, DerekBauer, MatthiasBoeckler, Frank MichaelEngel, MatthiasHartmann, Rolf WolfgangZhang, YanpingPiazza, Gary Anthony and Abadi, Ashraf Hassan
Chemical and Pharmaceutical Bulletin, vol. 64, (no. 1), pp. 41, 2016. | Journal Article
2015
Phosphodiesterase 10A: a novel target for selective inhibition of colon tumor cell growth and β-catenin-dependent TCF transcriptional activity.
Li, NLee, KXi, YZhu, BGary, B DRamírez-Alcántara, VGurpinar, ECanzoneri, J CFajardo, ASigler, SPiazza, J TChen, XAndrews, JThomas, MLu, WLi, YLaan, D JMoyer, M PRusso, SEberhardt, B TYet, LKeeton, A BGrizzle, W E and Piazza, G A
Oncogene, vol. 34, (no. 12), pp. 1499-1509, March 19, 2015. | Journal Article
 
Suppression of β-catenin/TCF transcriptional activity and colon tumor cell growth by dual inhibition of PDE5 and 10.
Li, NanChen, XiZhu, BingRamírez-Alcántara, VerónicaCanzoneri, Joshua CLee, KevinSigler, SaraGary, BernardLi, YongheZhang, WeiMoyer, Mary PSalter, E AlanWierzbicki, AndrzejKeeton, Adam B and Piazza, Gary A
Oncotarget, vol. 6, (no. 29), pp. 27403-27415, September 29, 2015. | Journal Article
2014
Novel non-cyclooxygenase inhibitory derivatives of naproxen for colorectal cancer chemoprevention
Aboul-Fadl, T.Al-Hamad, S.S.Lee, K.Li, N.Gary, B.D.Keeton, A.B.Piazza, G.A. and Abdel-Hamid, M.K.
Medicinal Chemistry Research, vol. 23, pp. 4177-4188. | Journal Article
2013
6-Aryl and heterocycle quinazoline derivatives as potent EGFR inhibitors with improved activity toward gefitinib-sensitive and -resistant tumor cell lines.
Hamed, Mostafa MAbouElElla, D.A.Abou El Ella, Dalal AKeeton, Adam BPiazza, Gary AAbadi, Ashraf HHartmann, Rolf W and Engel, Matthias
ChemMedChem, vol. 8, (no. 9), pp. 1495-1504, September 2013. | Journal Article
 
A novel sulindac derivative inhibits lung adenocarcinoma cell growth through suppression of Akt/mTOR signaling and induction of autophagy.
Gurpinar, EvrimGrizzle, William EShacka, JohnMader, Burton JLi, NanPiazza, Nicholas ARusso, SuzanneKeeton, Adam B and Piazza, Gary A
Molecular cancer therapeutics, vol. 12, (no. 5), pp. 663-74, 2013/May. | Journal Article
 
New NSAID targets and derivatives for colorectal cancer chemoprevention
Tinsley, H.N.Grizzle, W.E.Abadi, A.Keeton, A.Zhu, B.Xi, Y. and Piazza, G.A.
(pp. 105-120)
 
Quinazoline and tetrahydropyridothieno[2,3-d]pyrimidine derivatives as irreversible EGFR tyrosine kinase inhibitors: Influence of the position 4 substituent
Hamed, M.M.Abou El Ella, D.A.Keeton, A.B.Piazza, G.A.Engel, M.Hartmann, R.W. and Abadi, A.H.
MedChemComm, vol. 4, pp. 1202-1207. | Journal Article
 
Sulindac selectively inhibits colon tumor cell growth by activating the cGMP/PKG pathway to suppress Wnt/β-catenin signaling.
Li, NanXi, YaguangTinsley, Heather NGurpinar, EvrimGary, Bernard DZhu, BingLi, YongheChen, XiKeeton, Adam BAbadi, Ashraf HMoyer, Mary PGrizzle, William EChang, Wen-ChiClapper, Margie L and Piazza, Gary A
Molecular cancer therapeutics, vol. 12, (no. 9), pp. 1848-59, 2013/Sep. | Journal Article
 
Synthesis of some dihydropyrimidine-based compounds bearing pyrazoline moiety and evaluation of their antiproliferative activity
Awadallah, F.M.Piazza, G.A.Gary, B.D.Keeton, A.B. and Canzoneri, J.C.
European Journal of Medicinal Chemistry, vol. 70, pp. 273-279. | Journal Article
 
Trisubstituted and tetrasubstituted pyrazolines as a novel class of cell-growth inhibitors in tumor cells with wild type p53
Abdel-Halim, M.Keeton, A.B.Gurpinar, E.Gary, B.D.Vogel, S.M.Engel, M.Piazza, G.A.Boeckler, F.M.Hartmann, R.W. and Abadi, A.H.
Bioorganic and Medicinal Chemistry, vol. 21, pp. 7343-7356. | Journal Article
2012
A novel sulindac derivative that potently suppresses colon tumor cell growth by inhibiting cGMP phosphodiesterase and β-catenin transcriptional activity.
Whitt, Jason DLi, NanTinsley, Heather NChen, XiZhang, WeiLi, YongheGary, Bernard DKeeton, Adam BXi, YaguangAbadi, Ashraf HGrizzle, William E and Piazza, Gary A
Cancer prevention research (Philadelphia, Pa.), vol. 5, (no. 6), pp. 822-833, June 2012. | Journal Article
2011
A high-throughput screen with isogenic PTEN+/+ and PTEN-/- cells identifies CID1340132 as a novel compound that induces apoptosis in PTEN and PIK3CA mutant human cancer cells.
Li, Hui-FangKeeton, AdamVitolo, Michele IMaddox, ClintonRasmussen, LynnHobrath, JudithLucille White, E.White, E LPark, Ben HPiazza, Gary AKim, Jung-Sik and Waldman, Todd
Journal of biomolecular screening : the official journal of the Society for Biomolecular Screening, vol. 16, (no. 4), pp. 383-93, 2011/Apr. | Journal Article
 
Inhibition of PDE5 by sulindac sulfide selectively induces apoptosis and attenuates oncogenic Wnt/β-catenin-mediated transcription in human breast tumor cells.
Tinsley, Heather NGary, Bernard DKeeton, Adam BLu, WenyanLi, Yonghe and Piazza, Gary A
Cancer prevention research (Philadelphia, Pa.), vol. 4, (no. 8), pp. 1275-1284, August 2011. | Journal Article
2010
Colon tumor cell growth-inhibitory activity of sulindac sulfide and other nonsteroidal anti-inflammatory drugs is associated with phosphodiesterase 5 inhibition.
Tinsley, Heather NGary, Bernard DThaiparambil, JoseLi, NanLu, WenyanLi, YongheMaxuitenko, Yulia YKeeton, Adam B and Piazza, Gary A
Cancer prevention research (Philadelphia, Pa.), vol. 3, (no. 10), pp. 1303-1313, October 2010. | Journal Article
 
NSAIDs: Old Drugs Reveal New Anticancer Targets
Piazza, Gary AKeeton, Adam BTinsley, Heather NWhitt, Jason DGary, Bernard DMathew, BiniSingh, RajGrizzle, William E and Reynolds, Robert C
(pp. 1652-1667). 2010
2009
A novel sulindac derivative that does not inhibit cyclooxygenases but potently inhibits colon tumor cell growth and induces apoptosis with antitumor activity.
Piazza, Gary AKeeton, Adam BTinsley, Heather NGary, Bernard DWhitt, Jason DMathew, BiniThaiparambil, JoseCoward, LoriGorman, GregoryLi, YongheSani, BrahmaHobrath, Judith VMaxuitenko, Yulia Y and Reynolds, Robert C
Cancer prevention research (Philadelphia, Pa.), vol. 2, (no. 6), pp. 572-580, June 2009. | Journal Article
 
Assay for isolation of inhibitors of her2-kinase expression.
Chiosis, Gabriela and Keeton, Adam B
Methods in molecular biology (Clifton, N.J.), vol. 486, pp. 139-49, 2009. | Journal Article
 
Sulindac sulfide selectively inhibits growth and induces apoptosis of human breast tumor cells by phosphodiesterase 5 inhibition, elevation of cyclic GMP, and activation of protein kinase G
Tinsley, H.N.Gary, B.D.Keeton, A.B.Zhang, W.Abadi, A.H.Reynolds, R.C. and Piazza, G.A.
Molecular Cancer Therapeutics, vol. 8, pp. 3331-3340. | Journal Article
 
Suppression of Wnt/beta-catenin signaling inhibits prostate cancer cell proliferation.
Lu, WenyanTinsley, Heather NKeeton, AdamQu, ZhicanPiazza, Gary A and Li, Yonghe
European journal of pharmacology, vol. 602, (no. 1), pp. 8-14, January 5, 2009. | Journal Article
 
Synthesis of novel tadalafil analogues and their evaluation as phosphodiesterase inhibitors and anticancer agents
Abadi, A.H.Abouel-Ella, D.A.Ahmed, N.S.Gary, B.D.Thaiparambil, J.T.Tinsley, H.N.Keeton, A.B. and Piazza, G.A.
Arzneimittel-Forschung/Drug Research, vol. 59, pp. 415-421. | Journal Article